The medicines decisions made at the NENC Clinical Effectiveness and Governance (CEG) Subcommittee October 2025 meeting can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/

This includes the recommendations made by NTAG at its September 2025 meeting and NICE Technology appraisals from the 1st June 2025 to 31st July 2025 plus the 30-day NICE TA1094 and TA1095.

The following new guidelines were approved and can be found at:

The following reviewed guidelines were approved and can be found at:

The following shared care guidelines have had their review date extended until March 2026 and are available at: https://ntag.nhs.uk/shared-care-guidelines/

  • NENC Shared Care Protocol – Amiodarone for patients in adult services
  • NENC Shared Care Protocol – Dronedarone for patients in adult services

The following guidelines approved at NENC Clinical Effectiveness and Governance (CEG) Subcommittee June 2025 and August 2025 meeting have also now been published: